Fundz

Nuvation Bio Appoints Colleen Sjogren as Chief Commercial Officer

PUBLIC · NUVBMar 28, 2024

Position

Chief Commercial Officer

Company

Nuvation Bio

Colleen Sjogren
colleen.sjogren@nuvationbio.com
New YorkBiotechnologyHealthcareHealth CareTherapeuticsBiopharma

Description

Nuvation Bio Inc. announces the appointment of Colleen Sjogren as Chief Commercial Officer

Quick answer

Nuvation Bio Appoints Colleen Sjogren as Chief Commercial Officer (March 28, 2024). Nuvation Bio is based in New York, New York, United States.

Who is the new Chief Commercial Officer at Nuvation Bio?
Nuvation Bio named Colleen Sjogren Chief Commercial Officer, announced March 28, 2024.
What did Nuvation Bio announce on March 28, 2024?
Nuvation Bio Inc. announces the appointment of Colleen Sjogren as Chief Commercial Officer
What does Nuvation Bio do?
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates.
Where is Nuvation Bio based?
Nuvation Bio is based in New York, New York, United States.
Which similar companies made leadership changes around the same time?
Madrigal Pharmaceuticals (March 11, 2024), Verastem Oncology (April 18, 2024), AbbVie Inc. (February 20, 2024) and AVEO Pharmaceuticals (March 25, 2024) also announced leadership changes within 45 days of Nuvation Bio.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Nuvation Bio, and when

A new leader at Nuvation Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Nuvation Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nuvation Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nuvation Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nuvation Bio

Location

New York, New York, United States

About

Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s proprietary portfolio includes mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco. For more information, please visit www.nuvationbio.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nuvation Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Colleen
Likely contact at this company
••••••••@••••••••

See Colleen's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Nuvation Bio's next move

Learn about Strategic plan

Nuvation Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.